Amy Abernethy is co-founder of Highlander Health, with a healthcare career marked by changemaking in organizations ranging from Flatiron Health to Duke University School of Medicine and most recently, Verily, where she was President of Product Development and Chief Medical Officer, bringing her extensive leadership and medical expertise to the forefront of health and life sciences technology.

Prior to Verily, Dr. Abernethy served as the Principal Deputy Commissioner and Acting Chief Information Officer of the US Food & Drug Administration (FDA), where she was integral to the agency's modernization efforts, fostering a culture of innovation and data-driven decision making.

Her board roles span public companies such as athenahealth and CareDx to private firms including insitro and Georgiamune. In addition to her standard setting and innovation work, Dr. Abernethy is a hematologist/oncologist, palliative medicine physician, and author of over 500 publications and counting.

Dr. Abernethy received her MD from Duke University Medical School, where she later served as a Professor of Medicine. She also holds a PhD from Flinders University in Australia.

Health, Healthcare, TED, Healthcare Policy, Business of Healthcare, Innovation, Physician, Oncology, Science, Research & Exploration, Professors, Duke University, North Carolina, Women, Female Leadership, Influential Women, Data, Milken Institute, Artificial Intelligence